Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the α6β4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion

Molecular and Cellular Biology

Volumn 21, Issue 15, 2001, Pages 5082-5093

  Shaw, L M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CELL SURFACE RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTEGRIN; INULIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CANCER INVASION; CARCINOMA CELL; ENZYME ACTIVATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID MOTIFS; ANTIGENS, SURFACE; CELL ADHESION; COLLAGEN; CYTOPLASM; DNA, COMPLEMENTARY; ENZYME ACTIVATION; HUMANS; IMMUNOBLOTTING; INTEGRIN ALPHA6BETA4; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MUTAGENESIS, SITE-DIRECTED; NEOPLASM INVASIVENESS; PHOSPHOPROTEINS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0034951677     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.15.5082-5093.2001     Document Type: Article

References (86)

1. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
2. Activation of p53 function in carcinoma cells by the alpha6beta4 integrin
3. p53 inhibits alpha 6 beta 4 integrin survival signaling by promoting the caspase 3-dependent cleavage of AKT/PKB
4. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling
5. E-cadherin as a tumor (invasion) suppressor gene
6. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype
7. Structure and function of hemidesmosomes: More than simple adhesion complexes
8. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells
9. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
10. Specificity in recognition of phosphopeptides by src-homology 2 domains
11. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
12. A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells
13. A novel structural variant of the human beta 4 integrin cDNA
14. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor
15. Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes
16. Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors
17. The multiple roles of PTEN in tumor suppression
18. Beta-4 integrin is required for hemidesmosome formation, cell adhesion and cell survival
19. Regulation of neuronal survival by the serine-threonine protein kinase Akt
20. Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines
21. Monoclonal antibody to human carcinoma-associated protein complex: Quantitation in normal and tumor tissue
22. Integrin beta 4 expression in colorectal cancer
23. Stimulation of IRS-1-associated phosphatidylinositol 3-kinase and Akt/protein kinase B but not glucose transport by beta1-integrin signaling in rat adipocytes
24. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells
25. Interaction of insulin receptor substrate-2 (IRS-2) with the insulin and insulin-like growth factor I receptors. Evidence for two distinct phosphotyrosine-dependent interaction domains within IRS-2
26. Cloning and sequence analysis of beta-4 cDNA: An integrin subunit that contains a unique 118 kd cytoplasmic domain
27. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2
28. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-1, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells
29. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases
30. Adhesion molecules in cancer: The role of integrins
31. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth
32. Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways
33. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal
34. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
35. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer
36. Cell migration: A physically integrated molecular process
37. Insulin receptor substrate-1 as a signaling molecule for focal adhesion kinase pp125(FAK) and pp60(src)
38. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo
39. Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells
40. The integrin alpha 6 beta 4 is a laminin receptor
41. JAK/STAT signaling by cytokine receptors
42. Signal transduction by the alpha 6 beta 4 integrin: Distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes
43. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain
44. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85
45. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling
46. Role of IRS-1-GRB-2 complexes in insulin signaling
47. Integrin alpha 6 beta 4 forms a complex with the cytoskeletal protein HD1 and induces its redistribution in transfected COS-7 cells
48. Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma
49. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells
50. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism
51. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells
52. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2
53. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures
54. The integrin alpha 6 beta 4 and the biology of carcinoma
55. Protein kinase C-dependent mobilization of the alpha6beta4 integrin from hemidesmosomes and its association with actin-rich cell protrusions drive the chemotactic migration of carcinoma cells
56. Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: Direct interaction between the beta4 subunit and plectin at multiple molecular sites
57. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival
58. Structure, function, and biology of SHIP proteins
59. Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells
60. Alphabeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF
61. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue
62. Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor
63. Activation of phosphoinositide 3-OH kinase by the alpha-6-beta-4 integrin promotes carcinoma invasion
64. Regulation of B cell signal transduction by SH2-containing protein-tyrosine phosphatases
65. IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: Relationship with the inhibitory effect of IL-13 on ROI production
66. Downstream events in mammary gland morphogenesis mediated by reexpression of the alpha2beta1 integrin: The role of the alpha6 and beta4 integrin subunits
67. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation
68. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
69. Amino acid sequence of a novel integrin beta 4 subunit and primary expression of the mRNA in epithelial cells
70. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells
71. Epithelial integrin alpha 6 beta 4: Complete primary structure of alpha 6 and variant forms of beta 4
72. A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype
73. The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway
74. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: Implications for acquisition of the invading phenotype
75. Signalling through the lipid products of phosphoinositide-3-OH kinase
76. Insulin-like growth factor-I receptor overexpression mediates cellular radio-resistance and local breast cancer recurrence after lumpectomy and radiation
77. Interferon-dependent activation of the serine kinase PI 3′-kinase requires engagement of the IRS pathway but not the Stat pathway
78. Inhibitory receptors, ITIM sequences and phosphatases
79. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes
80. Epithelial detachment due to absence of hemidesmosomes in integrin beta-4 null mice
81. The A9 antigen associated with aggressive human squamous carcinoma is structurally and functionally similar to the newly defined integrin alpha 6 beta 4
82. Association of insulin receptor substrate-1 with integrins
83. The insulin signalling system and the IRS proteins
84. Disruption of IRS-2 causes type 2 diabetes in mice
85. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase